SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Serina Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.65−0.07 (-4.07%)
Close on Oct 19, 2026
- Market cap
- $27.04M
- P/E (TTM)
- –
- Dividend yield
- –
Serina Therapeutics, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Grant revenues | $130.00K | $56.00K | $153.00K | – | $104.00K | $307.00K | $180.00K | $20.00K | – | 100.0% | +132.1% |
| Subscription and Advertisement Revenues [Member] | – | – | – | – | $300.00K | $1.30M | – | $1.23M | $1.40M | – | – |
| Service and Other Revenues [Member] | – | – | – | – | – | – | – | $149.00K | $5.00K | – | – |
| Subscription and Advertisement Revenues [Member] | – | – | – | – | – | $1.27M | $1.30M | $1.23M | – | – | – |
| Other Revenues [Member] | – | – | $65.00K | $34.00K | $40.00K | $54.00K | $253.00K | $149.00K | – | – | – |
| Subscription and Advertisement [Member] | – | – | – | – | – | $1.27M | $1.30M | $1.23M | – | – | – |
| Grant [Member] | – | – | – | – | – | – | $180.00K | $20.00K | – | – | – |
| Service and Other Revenue [Member] | – | – | – | – | – | – | $216.00K | $149.00K | – | – | – |
| Subscription and Advertisement to Other Revenes [Member] | – | – | – | – | – | $37.00K | – | – | – | – | – |
| License revenues | – | $0 | $3.00M | – | – | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | $90.00K | $10.00K | $107.00K | $323.00K | $986.00K | $813.00K | $808.00K | – | – |
| Foreign [Member] | – | – | $52.00K | $24.00K | $37.00K | $38.00K | $742.00K | $583.00K | $596.00K | – | – |
From the segment and revenue-disaggregation notes of Serina Therapeutics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.